Phase I/IIa clinical trial of TB 403 in children and adolescents with medulloblastoma
Phase of Trial: Phase I/II
Latest Information Update: 11 Jul 2017
At a glance
- Drugs THR 317 (Primary)
- Indications Alveolar soft part sarcoma; Ewing's sarcoma; Medulloblastoma; Neuroblastoma
- Focus Adverse reactions
- Sponsors Oncurious
- 02 May 2016 According to an Oncurious media release, first results from this trial are expected in 2017.
- 02 May 2016 Status changed from not yet recruiting to recruiting, as reported in an Oncurious media release.
- 26 Apr 2016 According to a BioInvent International media release, first patient from this trial is expected to be dosed in May 2016.